10.04.2014 • News • automotives • Azoty • caprolactam feedstock

Grupa Azoty to Build New PA 6 Plant at Tarnow

Grupa Azoty, the Polish chemicals and plastics producer based at Tarnow, has announced plans for a second polyamide 6 production facility at its site in the the special economic zone at Tarnow.

The new 80,000 t/y plant, scheduled to go on stream in 2016, will cost around €77 million. It will be erected adjacent to an existing plant for which the company has not quantified capacity.

Both facilities will use caprolactam feedstock produced at the site.

Azoty said the new plant reflects rising demand for PA from the automotive sector and other industries using structural fibres. It also creates a captive outlet for the company's caprolactam production in the face of falling retail prices for the PA feedstock due to global overcapacity.

Due to the oversupply in China, the Polish company has abandoned plans for a production facility there.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Top-Feature

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
19.03.2025 • News • Innovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.